Eurobio-Scientific SA (ALERS) Financial Statements

1 Followers

Eurobio-Scientific SA Financial Overview

Eurobio-Scientific SA's market cap is currently €226.12M. The company's EPS TTM is €0.47; its P/E ratio is 50.93; Eurobio-Scientific SA is scheduled to report earnings on April 10, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 169.00M	€ 154.95M	€ 130.65M	€ 152.61M	€ 184.71M
Gross Profit	€ 68.40M	€ 71.95M	€ 57.49M	€ 65.04M	€ 97.44M
Operating Income	€ 10.80M	€ 13.40M	€ 10.14M	€ 30.87M	€ 71.99M
EBITDA	€ 19.70M	€ 20.40M	€ 24.55M	€ 40.49M	€ 79.63M
Net Income	€ 4.90M	€ 4.00M	€ 4.83M	€ 24.94M	€ 60.54M
Balance Sheet
Cash & Short-Term Investments	€ 20.66M	€ 23.07M	€ 89.03M	€ 85.94M	€ 102.39M
Total Assets	€ 256.76M	€ 257.17M	€ 316.33M	€ 330.42M	€ 209.22M
Total Debt	€ 16.02M	€ 34.05M	€ 100.66M	€ 113.60M	€ 15.68M
Net Debt	€ -4.30M	€ 12.28M	€ 52.03M	€ 66.11M	€ -77.24M
Total Liabilities	€ 72.83M	€ 78.31M	€ 141.16M	€ 157.75M	€ 49.00M
Stockholders' Equity	€ 183.92M	€ 178.85M	€ 175.17M	€ 172.34M	€ 159.91M
Cash Flow
Free Cash Flow	€ 6.28M	€ 13.45M	€ 22.71M	€ 39.01M	€ 63.61M
Operating Cash Flow	€ 18.85M	€ 16.70M	€ 26.77M	€ 41.85M	€ 65.46M
Investing Cash Flow	€ -12.89M	€ -10.74M	€ -318.00K	€ -141.76M	€ -5.47M
Financing Cash Flow	€ -8.16M	€ -72.09M	€ -23.50M	€ 82.31M	€ -23.75M

Currency in EUR

Eurobio-Scientific SA Earnings and Revenue History

Income Statement >

Eurobio-Scientific SA Debt to Assets

Balance Sheet >

Eurobio-Scientific SA Cash Flow

Cash Flow >

Eurobio-Scientific SA Forecast EPS vs Actual EPS

Earnings >